Insulin aspart, recombinant Subcutaneous and TOBI Podhaler
Determining the interaction of Insulin aspart, recombinant Subcutaneous and TOBI Podhaler and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: tobramycin
Brand name: Bethkis, Kitabis Pak, Tobi, TOBI Podhaler
Synonyms: Tobi Podhaler (inhalation), Tobi Podhaler
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Tobi Podhaler inhalation
- Insulin aspart, recombinant Subcutaneous-Tobradex
- Insulin aspart, recombinant Subcutaneous-TobraDex (Tobramycin and Dexamethasone Eye Drops)
- Insulin aspart, recombinant Subcutaneous-TobraDex (Tobramycin and Dexamethasone Eye Ointment)
- Insulin aspart, recombinant Subcutaneous-TobraDex Eye Drops
- Insulin aspart, recombinant Subcutaneous-Tobradex Ointment
- TOBI Podhaler-Insulin degludec
- TOBI Podhaler-Insulin Degludec (U-100) Prefilled Pens
- TOBI Podhaler-Insulin Degludec (U-100) Vials
- TOBI Podhaler-Insulin Degludec (U-200) Prefilled Pens
- TOBI Podhaler-Insulin degludec and liraglutide
- TOBI Podhaler-Insulin degludec and liraglutide Subcutaneous